Inspira Technologies Oxy B.H.N. Stock Price, News & Analysis (NASDAQ:IINN) $1.06 -0.04 (-3.20%) (As of 03:51 PM ET) Add Compare Share Share Today's Range$1.05▼$1.1350-Day Range$1.02▼$1.5252-Week Range$0.98▼$1.99Volume38,021 shsAverage Volume42,845 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice Target$13.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Inspira Technologies Oxy B.H.N. MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,115.0% Upside$13.00 Price TargetShort InterestHealthy0.13% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.98Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.18) to ($0.70) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.27 out of 5 stars 3.5 Analyst's Opinion Consensus RatingInspira Technologies Oxy B.H.N. has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $13.00, Inspira Technologies Oxy B.H.N. has a forecasted upside of 1,115.0% from its current price of $1.07.Amount of Analyst CoverageInspira Technologies Oxy B.H.N. has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.13% of the float of Inspira Technologies Oxy B.H.N. has been sold short.Short Interest Ratio / Days to CoverInspira Technologies Oxy B.H.N. has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inspira Technologies Oxy B.H.N. has recently increased by 141.18%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldInspira Technologies Oxy B.H.N. does not currently pay a dividend.Dividend GrowthInspira Technologies Oxy B.H.N. does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IINN. Previous Next 2.8 News and Social Media Coverage News SentimentInspira Technologies Oxy B.H.N. has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Inspira Technologies Oxy B.H.N. this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for IINN on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inspira Technologies Oxy B.H.N. insiders have not sold or bought any company stock.Percentage Held by Insiders29.40% of the stock of Inspira Technologies Oxy B.H.N. is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Inspira Technologies Oxy B.H.N. are expected to grow in the coming year, from ($1.18) to ($0.70) per share.Price to Book Value per Share RatioInspira Technologies Oxy B.H.N. has a P/B Ratio of 0.65. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Inspira Technologies Oxy B.H.N. Stock (NASDAQ:IINN)Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.Read More IINN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IINN Stock News HeadlinesNovember 30, 2023 | finance.yahoo.comInspira (IINN) Expands in Life Support Space With New DealNovember 29, 2023 | finance.yahoo.comInspira Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU PatientsDecember 5, 2023 | Financial Alphas (Ad)Countries Are Investing Heavily Into Securing Energy IndependenceThere's a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub.November 16, 2023 | msn.comInspira Technologies Oxy B.H.N. reports 9M resultsNovember 16, 2023 | finanznachrichten.deInspira Technologies Reports Third Quarter 2023 Financial ResultsNovember 16, 2023 | finance.yahoo.comInspira™ Technologies Reports Third Quarter 2023 Financial ResultsNovember 6, 2023 | finance.yahoo.comInspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation TechnologyOctober 25, 2023 | finance.yahoo.comInspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical DeviceDecember 5, 2023 | Financial Alphas (Ad)Countries Are Investing Heavily Into Securing Energy IndependenceThere's a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub.October 24, 2023 | msn.comInspira Technologies terminates its at-the-market equity offeringOctober 24, 2023 | finance.yahoo.comInspira™ Terminates ATM Program and Provides an UpdateOctober 11, 2023 | money.usnews.comInspira Technologies Oxy B.H.N. LtdOctober 10, 2023 | finance.yahoo.comInspira™ Enters into a Distribution Agreement in Central America with CIO MED GROUPSeptember 28, 2023 | finance.yahoo.comInspira™ Technologies Unveils the INSPIRA™ ART Line of Medical Devices at the World's Largest Extracorporeal Life Support ConferenceSeptember 13, 2023 | finance.yahoo.comInspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards CommercializationAugust 31, 2023 | finance.yahoo.comInspira (IINN) Advances Foothold in Europe With Extended DealAugust 29, 2023 | finance.yahoo.comInspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical DevicesAugust 11, 2023 | msn.comInspira Technologies Oxy B.H.N. reports Q2 resultsAugust 10, 2023 | finanznachrichten.deInspira Technologies Reports Second Quarter 2023 Financial ResultsAugust 10, 2023 | finance.yahoo.comInspira™ Technologies Reports Second Quarter 2023 Financial ResultsAugust 9, 2023 | finance.yahoo.comINSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.July 24, 2023 | finance.yahoo.comInspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory ApprovalJuly 19, 2023 | finance.yahoo.comInspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.June 15, 2023 | finance.yahoo.comInspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory CareMay 30, 2023 | finance.yahoo.comInspira Technologies Appoints Dr. Nir as Chief Medical OfficerMay 18, 2023 | finanznachrichten.deInspira Technologies Reports First Quarter 2023 Financial ResultsMay 18, 2023 | finance.yahoo.comInspira™ Technologies Reports First Quarter 2023 Financial ResultsSee More Headlines Receive IINN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspira Technologies Oxy B.H.N. and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today12/05/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:IINN CUSIPN/A CIK1837493 Webinspira-technologies.com Phone972-4623-0333FaxN/AEmployees32Year FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$13.00 Low Stock Price Target$13.00 Potential Upside/Downside+1,115.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,270,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-128.07% Return on Assets-94.22% Debt Debt-to-Equity Ratio0.18 Current Ratio3.34 Quick Ratio3.34 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.64 per share Price / Book0.65Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta1.90 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Dagi Shahar Ben-Noon (Age 47)Co-Founder, CEO & Director Comp: $369.43kMr. Joe Hayon (Age 49)Co-Founder, President & Director Comp: $384.1kMs. Yafit Tehila (Age 41)CFO and Principle Financial & Accounting Officer Comp: $265.04kMr. Avi Shabtai (Age 49)COO and VP of Research & Development Comp: $310.42kMs. Daniella Yeheskely-Hayon Ph.D. (Age 47)Chief Technology Officer Comp: $237.87kMeshira GreenbergAdministrative ManagerAdi ShmueliMarketing & Communications ManagerOdelya Ben-Asher DekelHuman Resources ManagerMs. Adi Rizansky Nir Ph.D.Chief Medical OfficerMore ExecutivesKey CompetitorsNyxoahNASDAQ:NYXH60 Degrees PharmaceuticalsNASDAQ:SXTPWAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAllena PharmaceuticalsNASDAQ:ALNAQView All Competitors IINN Stock Analysis - Frequently Asked Questions Should I buy or sell Inspira Technologies Oxy B.H.N. stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspira Technologies Oxy B.H.N. in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" IINN shares. View IINN analyst ratings or view top-rated stocks. What is Inspira Technologies Oxy B.H.N.'s stock price target for 2024? 1 brokers have issued 12-month price targets for Inspira Technologies Oxy B.H.N.'s stock. Their IINN share price targets range from $13.00 to $13.00. On average, they anticipate the company's share price to reach $13.00 in the next year. This suggests a possible upside of 1,115.0% from the stock's current price. View analysts price targets for IINN or view top-rated stocks among Wall Street analysts. How have IINN shares performed in 2023? Inspira Technologies Oxy B.H.N.'s stock was trading at $1.29 on January 1st, 2023. Since then, IINN shares have decreased by 17.1% and is now trading at $1.07. View the best growth stocks for 2023 here. Are investors shorting Inspira Technologies Oxy B.H.N.? Inspira Technologies Oxy B.H.N. saw a increase in short interest in November. As of November 15th, there was short interest totaling 8,200 shares, an increase of 141.2% from the October 31st total of 3,400 shares. Based on an average daily volume of 22,100 shares, the short-interest ratio is currently 0.4 days. Currently, 0.1% of the shares of the stock are short sold. View Inspira Technologies Oxy B.H.N.'s Short Interest. When did Inspira Technologies Oxy B.H.N. IPO? (IINN) raised $19 million in an initial public offering (IPO) on Wednesday, July 14th 2021. The company issued 2,909,091 shares at a price of $5.50-$7.50 per share. How do I buy shares of Inspira Technologies Oxy B.H.N.? Shares of IINN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:IINN) was last updated on 12/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspira Technologies Oxy B.H.N. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.